WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Monday reported a loss of $24.5 million in its first quarter.

The Waltham, Massachusetts-based company said it had a loss of 72 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 39 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share.

The specialty drugmaker posted revenue of $68.7 million in the period, exceeding Street forecasts. Six analysts surveyed by Zacks expected $64.9 million.

AMAG Pharmaceuticals shares have declined 24% since the beginning of the year. The stock has declined 18% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMAG at https://www.zacks.com/ap/AMAG

Automated Insights, source Associated Press News